Legal & General Group Plc - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18,798
-11.4%
1,952
-17.2%
0.00%
Q2 2023$21,213
+14.5%
2,3570.0%0.00%
Q1 2023$18,526
+16.3%
2,3570.0%0.00%
Q4 2022$15,933
-53.1%
2,3570.0%0.00%
Q3 2022$34,000
+70.0%
2,357
+14.8%
0.00%
Q2 2022$20,000
-50.0%
2,053
-26.0%
0.00%
Q1 2022$40,000
+8.1%
2,7730.0%0.00%
Q4 2021$37,000
-11.9%
2,773
+13.1%
0.00%
Q3 2021$42,000
-28.8%
2,4520.0%0.00%
Q2 2021$59,000
+37.2%
2,452
+47.2%
0.00%
Q1 2021$43,000
+72.0%
1,666
+26.4%
0.00%
Q4 2020$25,000
+47.1%
1,3180.0%0.00%
Q3 2020$17,000
-19.0%
1,318
-24.1%
0.00%
Q2 2020$21,000
+31.2%
1,736
-17.3%
0.00%
Q1 2020$16,000
-60.0%
2,099
-13.3%
0.00%
Q4 2019$40,000
+73.9%
2,422
+24.6%
0.00%
Q3 2019$23,000
-46.5%
1,9440.0%0.00%
Q2 2019$43,0001,9440.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 422,310$10,849,0005.86%
COMMODORE CAPITAL LP 214,467$5,510,0002.20%
Vivo Capital, LLC 1,863,296$47,868,0001.68%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 214,533$5,486,0001.45%
Nicholas Investment Partners, LP 594,130$15,263,0001.06%
Altium Capital Management LP 128,130$3,292,0000.91%
Affinity Asset Advisors, LLC 100,000$2,569,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 50,000$1,285,0000.70%
APIS CAPITAL ADVISORS, LLC 30,000$771,0000.70%
Birchview Capital, LP 40,000$1,028,0000.61%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders